Table 5.
Distributions of the Causative Agents’ Exposure Over the Period (March through May) of 2016-2020
| Causative Agents | Years | |
|---|---|---|
| χ2 (Chi Square Test) | P | |
| Anticholinesterase Compounds | 29.324 | <.001a |
| 2016 (z = - 2.1) | ||
| 2017 (z = 3.0) | ||
| 2020 (z = - 4.4) | ||
| Analgesic and Antipyretic | 25.922 | .006 a |
| 2016 (z = 4.9) | ||
| 2020 (z = - 2.1) | ||
| Phosphides | 34.295 | <.001a |
| 2016 (z = - 4.5) | ||
| 2019 (z = 2.4) | ||
| 2020 (z = 3.5) | ||
| Corrosives and Hydrocarbons | 9.949 | .041a |
| 2018 (z = 2.0) | ||
| Antipsychotics | 21.494 | <.001a |
| 2016 (z = - 2.9) | ||
| 2020 (z = 3.6) | ||
| Cardiovascular Drugs & Xanthine Derivatives | 13.687 | .008a |
| 2016 (z = 3.3) | ||
| 2018 (z = - 2.4) | ||
| Others | 15.124 | .004a |
| 2016 (z = 3.5) | ||
| 2019 (z = - 2.0) | ||
a
P value <.05 (statistically significant).